(<2.0 g/day). The both scores of glomerulosclerosis and interstitial fibrosis were positively correlated with Background. Recent reports describe that erythropoietin (Epo) is produced by peritubular interstitial the u-NAG levels (each P<0.001), but were not correlated with the Epo levels. fibroblast-like cells in response to a hypoxic stimulus. We studied serum Epo levels as a possible marker of Conclusions. The significant correlation between u-NAG and serum Epo levels suggests that tubular tubulointerstitial damage in the progression of IgA nephropathy (IgAN ), in comparison with urinary (u-) damage and interstitial cell dysfunction are associated each other in the progression of IgAN. Serum Epo levels of N-acetyl-b--glucosaminidase (NAG), which is mainly derived from proximal tubular cells and is levels bearing inverse correlations with sCr, blood pressure levels and heavy proteinuria seem to reflect used as a marker of tubular damage. Methods. Thirty-eight patients with IgA nephropathy clinical severity of IgAN, whereas u-NAG can be more useful progression marker of IgAN bearing correla-(IgAN ) with relatively preserved renal function (serum creatinine: sCr, 0.5-2.2 mg/dl ) were examined. The tions with both clinical and histological findings. severity of glomerulosclerosis and interstitial fibrosis
obtained in the morning and u-NAG was measured Introduction by colorimetric method of 24-h urine samples. Results. The mean Epo level of the patients (17.7±6. 3 Tubulointerstitial lesions, characterized by tubular mU/ml ) was not different from the control level atrophy, interstitial fibrosis, and inflammatory cell (19.3±3.7 mU/ml ). There were no significant correlainfiltration, play a pivotal role in the progression of tions between Epo levels and red blood cell (RBC ) renal diseases including primary glomerulopathies counts, haematocrit (Hct), or haemoglobin (Hb) [1] [2] [3] [4] . In the development of chronic tubular damage levels. The mean u-NAG level of the patients (6.7±6. 2 in primary glomerulonephritis, it has been suggested U/gCr) was significantly higher than the control level that filtered proteins and inflammatory cytokines (1.9±0.5 U/gCr). There was an inverse quantitative released from nephritic glomeruli stimulate tubular correlation between Epo and u-NAG levels in the cells, which may subsequently produce and release patients (P<0.02). The u-NAG levels showed quanchaemoattractant substances and fibrogenic factors. titative positive correlations with sCr (P<0.001), Consequently, interstitial fibroblast activation and u-proteins (P<0.001), systolic (SBP) (P<0.001), and macrophage infiltration may be induced, leading to diastolic blood pressures (DBP) (P<0.05). Conversely, interstitial fibrosis with tubular damage. In addition, Epo levels were inversely correlated with sCr, SBP the following mechanisms have been considered as and DBP (each P<0.05). The patients with higher accelerating factors; (i) the increase of oxygen conu-proteins (>2.0 g/day) showed significantly decreased sumption and production of reactive oxygen species in Epo levels (P<0.05) than those with lower u-proteins surviving nephrons, which causes further ammoniagenesis and complement activation, and (ii) hypertensive sclerosed area more than 2/3; and grade 4, complete obsoRecently, it has been shown that fibroblast-like lescence. Interstitial fibrosis was also semiquantitatively interstitial cells which exist between peritubular capilexpressed as the mean grade of each view on a microscopylaries and tubular cells are the source of circulating linked TV monitor at ×64 magnification: grade 0, no fibrosis;
Epo [8, 9] and that the production of Epo, dependent grade 1, fibrosis less than 10% of tubulointerstitial area; on the extent of low oxygen pressure, may be attenu-grade 2, fibrosis from 10 to 30%; and grade 3, fibrosis more ated in association with the decreased number of the than 30%. These findings were recorded after the observations corresponding fibroblastic cells and the phenotypic by three renal pathologists. change to myofibroblasts in experimental renal fibrosis [10, 11] . These findings suggest the presence of a cor-Urinary NAG test and serum Epo measurement relation between serum Epo levels and the degree of tubulointerstitial lesions in IgA nephropathy. The A portion of each 24-h urine sample was centrifuged, and measurement of the urinary levels of NAG, a lysosomal the supernatant was used for the urinary NAG test within enzyme abundant in proximal tubular segments [12] , 4 h of the collection. The urinary NAG levels were measured has been a useful marker to monitor tubular damage by a spectrophotometric method using 6-methyl-2-pyridyl-N-acetyl-1-thio-b--glucosaminide as the substrate with a in patients undergoing nephrotoxic therapy and in commercial kit (Shionogi Diagnostic Co., Tokyo, Japan).
those with nephrotic syndrome, glomerulonephritis, or
The results are expressed as units per gram of urine creatinine diabetic nephropathy [13, 14] . In the present study, to The patients with overt urinary tract infection were excluded To determine the importance of tubulointerstitial from this study. Urine samples were obtained from the 24-h lesions in IgA nephropathy, clinical parameters were in-hospital collection with clean bottles at the renal biopsy, compared with the glomerulosclerosis index and interand blood samples were obtained in the early morning stitial fibrosis index. The interstitial fibrosis index (range 9.4-16.7) respectively. There were no significant relationships between the Epo levels and any of these Renal biopsy parameters.
The renal biopsy materials were examined by light micro-
Relationship between NAG and Epo
scopy with H&E, periodic-acid Schiff (PAS), and silver methenamine (PAM ) stainings. Immunofluorescence staining The mean NAG level in the IgA nephropathy patients was applied for the detection of IgA, IgG, IgM, C3c, and was 6.7±6.2 U/gCr, significantly higher than the level fibrinogen. Glomerular sclerosis was expressed by the mean of the healthy controls (1.9±0.5 U/gCr); (P<0.002).
grade of each glomerulus: grade 0, normal or minor abnor-
The mean Epo level in the patients was 17.7±6.3 malities; grade 1, sclerosed area less than 1/3 of the glomerulus; grade 2, sclerosed area from 1/3 to 2/3; grade 3, mU/ml (range 9.5-36.2), which was not different from Table 1 . Correlations between clinical parameters and histological was significantly decreased (P<0.05) than the mean scores in patients with u-proteins lower than 2.0 g/day (18.9±6.5 mU/ml ) ( Figure 3D sCr, serum creatinine; U-proteins, urinary proteins; SBP, systolic The patients with higher scores of glomerulosclerosis blood pressure; DBP, diastolic blood pressure.
( Figure 5A ) or interstitial fibrosis ( Figure 5C ) showed more increased NAG levels in a significant relationship the control level (19.3±3.7 mU/ml ). Quantitatively, between these parameters (P<0.001 each). On the there was a significant inverse correlation (P<0.02) other hand, the Epo level was not correlated with the between the two tests, showing that the patients with glomerulosclerosis score ( Figure 5B ) nor with the interhigher NAG showed relatively lower Epo levels. Most stitial fibrosis score ( Figure 5D ). (7/9 cases) of the patients with an Epo level higher than the mean level (17.7 mU/ml ) belonged to the subgroup of patients with a NAG level lower than the Discussion mean level (6.7 U/gCr). Similarly, most (10/12 cases) of the patients with increased NAG compared to the In this study we first compared the degree of glomerulomean showed Epo levels lower than the mean level sclerosis and interstitial fibrosis with clinical para- (Figure 1 ). meters such as sCr, u-proteins, SBP, and DBP. We found that the interstitial fibrosis score showed strong correlations with all of these parameters
Relationship of NAG and Epo levels with clinical
(each P<0.001), whereas the glomerulosclerosis score parameters showed similar correlations with sCr and u-proteins Urinary NAG showed a significant quantitative cor-and, to a lesser extent, with SBP, with no relationship relation (P<0.001) with sCr ( Figure 2A ), and serum with DBP. These findings emphasize the clinical imporEpo showed an inverse correlation (P<0.05) with sCr, tance of tubulointerstitial damage in the progression i.e. lower Epo levels were seen in the patients with of IgAN. We next examined the clinical usage of higher sCr levels ( Figure 2B ). The NAG levels showed u-NAG as a marker of tubular damage in IgAN. We a significant quantitative correlation with the u-protein measured NAG levels in urine samples collected over levels (P<0.001) ( Figure 3A) . On the other hand, the 24 h in clean bottles from patients without urinaryEpo levels did not show significant correlation with tract infection, although fresh urine samples are preferthe u-protein levels ( Figure 3B) ; however, when the able for the enzyme activity. With this regard, patients were divided into two groups based on Wellwood et al. have shown that NAG activity was u-protein levels, the mean Epo level in patients with not changed after storage of urine samples for 24-48 h u-proteins higher than 2.0 g/day (13.4±3.0 mU/ml ) at 37°C if bacterial growth was avoided [15] , and the comparable results have been described utilizing 24-h u-NAG data in patients with various renal diseases [14, 16, 17] . In these papers it has been shown that there were positive correlations between u-NAG and u-protein levels in various types of primary glomerulonephritis [14, 17] , and the NAG levels were different according to the histological subtype of glomerulonephritis [16, 18] . These data seem to indicate that tubular injury may be caused by protein resorption and that u-NAG may reflect the activity of glomerulonephritis. In the present study of IgAN we found positive correlations of u-NAG not only with u-proteins but also with sCr, SBP, and DBP, and with the interstitial fibrosis score. These results indicate that Fig. 1 . Relationship between urinary NAG levels and serum erythro-u-NAG measurement may be a highly beneficial clinpoietin ( EPO) levels in the IgA nephropathy patients. There was a ical marker of the severity of IgAN, reflecting the significant inverse correlation between the two parameters (P<0.02). Dotted lines indicate the mean levels of the patients. degree of tubulointerstitial damage. Fig. 2 . Relationship between serum creatinine (sCr) and urinary NAG levels (A) and between sCr and serum erythropoietin (EPO) levels (B) in the IgA nephropathy patients. There was a positive correlation between sCr and NAG (P<0.001), and an inverse correlation between sCr and EPO (P<0.05). The beneficial effects of recombinant human Epo in Toxic metabolites produced in renal failure are thought to be antagonists of Epo synthesis [19] . Taking into the treatment of anaemia in chronic renal failure have been established [19] , but there are only a few papers account the accumulating evidence that different cytokines contribute to the progression of IgAN; for on the endogenous circulating Epo levels in the progression of renal disease [20] [21] [22] . Inomata et al. example, PDGF in the mesangial cell proliferation and TGF b in the fibrogenic process [6 ] , and that Epo reported that low serum Epo might be a new predicting marker of the progression of diabetic nephropathy stimulates vascular endothelial cells and causes vasoconstriction [27, 28] , the circulating Epo levels in [20] , and the laboratories of Nielsen and Thaysen have shown Epo deficiency in patients with acute renal patients with IgAN should be determined.
We examined the relationship between u-NAG and failure, including crescentic glomerulonephritis [21, 22] . However, these reports did not describe the relation-serum Epo levels, and the relationship of Epo with u-proteins, sCr, blood pressures, and the histological ship between Epo levels and tubular damage, notwithstanding the fact that Epo is produced in peritubular scores of glomerulosclerosis and interstitial fibrosis.
Serum samples for the Epo measurement were obtained interstitial cells. Recent molecular studies have shown that Epo production responsive to hypoxia is mediated early in the morning at the renal biopsy, because a study of the circadian rhythm of serum Epo levels has by hypoxia-inducible factor-1 (HIF-1), which also stimulates platelet-derived growth factor (PDGF ) and shown the basal level in the morning and the highest level (a 60% increase) at 8.00 p.m. [29] . In contrast to vascular endothelial growth factor [23, 24] . Other inflammatory cytokines such as tumour necrosis factor, the discrepancy between the Epo levels in the patients being in a range similar to the control levels and the IL-1 and transforming growth factor b ( TGF b) are known as antagonists for Epo production [25, 26 ] . u-NAG levels in the patients being higher than the When the patients were divided into four groups of high and low levels of both Epo and NAG based on the mean levels, most of the patients with high Epo showed low NAG, and most of those with high NAG showed low Epo. This finding suggests that in mild injury of tubular cells, interstitial cells may be activated, contributing to the relatively higher Epo levels, whereas in advanced tubular damage as shown by increased urinary NAG levels, the interstitial fibroblasts may be in a state of dysfunction, bearing phenotypic changes similar to those of myofibroblasts producing lower Epo levels [30, 31] . In this regard, Maxwell et al. [11] proposed that in experimental models of interstitial renal disease, the proportion of Epo-producing cells may be decreased among interstitial fibroblast-like cells bearing the myofibroblast phenotype, and these cells are partially refractory to hypoxic stimulation for Epo production.
In comparison with clinical parameters, Epo showed depressed Epo levels may be associated with the progression of IgAN. Recent studies have shown a positive control levels, we found an inverse quantitative correlaquantitative correlation between endogenous Epo tion between the serum Epo and the u-NAG levels.
levels and blood pressures in essential hypertension, The present data on Epo in the nearly normal range indicating that Epo may be a pathogenetic factor might be a reflection of the basal levels, because the through a vasoconstricting effect in the development serum samples were obtained in the morning, which of essential hypertension [32, 33] . However, such a might be easily stimulated to a wider range than the relationship was not observed in the present IgAN present levels by diurnal endocrine factor [29] or tissue patients. Rather, it seems likely that interstitial damage hypoxia based on histological and haemodynamic substantially enough to exhibit decreased Epo levels changes [10, 11] . Additional study based on Epo levels contributes to the development of renal hypertension. obtained at the peak level at 8.00 p.m. would be
The positive correlation between urinary proteins and beneficial in more elaborate comparisons with various clinical and histological parameters.
the NAG levels suggests the pathogenic role of urinary 
